Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

The news outlet is pushing the Commission to release text messages that the E.U.’s top official and Pfizer exchanged as they ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...

Pfizer's drug approvals and advertising revenue could be affected by RFK Jr.'s potential appointment. See why PFE stock is a ...

In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...

But the incumbents look set to fight to hold on to the market, with Alnylam Pharmaceuticals sharing early-phase data on its ...

Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

A U.S. stock rally fueled by Donald Trump’s election victory is stumbling, as investors contend with everything from renewed ...